Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approach

Colorectal cancer (CRC) is one of the most common cancers in the Western world. 5-Fluorouracil (5FU)-based chemotherapy (CT) remains the mainstay treatment of CRC in the advanced setting, and activates executioner caspases in target cells. Executioner caspases are key proteins involved in cell disas...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cell Death Dis
Autori principali: Flanagan, L, Meyer, M, Fay, J, Curry, S, Bacon, O, Duessmann, H, John, K, Boland, K C, McNamara, D A, Kay, E W, Bantel, H, Schulze-Bergkamen, H, Prehn, J H M
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2016
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4849164/
https://ncbi.nlm.nih.gov/pubmed/26844701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2016.7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi